Long term management of people with post-tuberculosis lung disease
Wan Seo, Hyung Woo Kim, Ju Sang Kim, Jinsoo Min
Korean J Intern Med. 2024;39(1):7-24. Published online January 1, 2024
Post-tuberculosis lung disease (PTLD) is emerging as a significant area of global interest. As the number of patients surviving tuberculosis (TB) increases, the subsequent long-term repercussions have drawn increased attention due to their profound clinical and socioeconomic impacts. A primary obsta..
|
|
Infectious diseases
Risk factors and clinical impact of COVID-19-associated pulmonary aspergillosis: Multicenter retrospective cohort study
Raeseok Lee, Sung-Yeon Cho, Dong-Gun Lee, Hyojin Ahn, Hyeah Choi, Su-Mi Choi, Jae-Ki Choi, Jung-Hyun Choi, Shin Young Kim, Youn Jeong Kim, Hyo-Jin Lee
Korean J Intern Med. 2022;37(4):851-863. Published online May 26, 2022
Background/Aims: The risk factors and clinical impacts of coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) remain controversial, and no data have been reported in Korea. This study aimed to investigate the epidemiology and importance of CAPA diagnostic efforts and to ide..
|
|
Invasive pulmonary aspergillosis in a patient with metastatic non-small cell lung cancer after
treatment with gefitinib
Sejeong Park, Soyoung Park, Hana Choi, Ji Young Park, Hyo Seok Lim, Myung Jae Park, Si-Young Kim
Korean J Intern Med. 2018;33(1):211-213. Published online November 25, 2016
|
|
Hyperglycemic hyperosmolar state associated with invasive rhino-orbital aspergillosis in a
patient with end-stage renal disease
Ju Hyun Seo, Jin Ah Kim, Bomi Choi, Kyo Hee Kim, Ha Neul Park, Hannah Seok, Tae Seo Sohn
Korean J Intern Med. 2017;32(5):936-938. Published online March 10, 2016
|
|
Infectious diseases
Voriconazole-refractory invasive aspergillosis
Se Yoon Park, Jung-A Yoon, Sung-Han Kim
Korean J Intern Med. 2017;32(5):805-812. Published online August 24, 2017
Invasive aspergillosis (IA) is one of the most common life-threatening complications in immunocompromised patients. Voriconazole is currently the drug of choice for IA treatment. However, some patients with IA suffer clinical deterioration despite voriconazole therapy. Management of voriconazole-ref..
|
|
Serum galactomannan levels in the diagnosis of invasive aspergillosis
Yildiz Okuturlar, Fahir Ozkalemkas, Beyza Ener, Sibel Ocak Serin, Esra Kazak, Tulay Ozcelik, Vildan Ozkocaman, Hasan Atilla Ozkan, Halis Akalin, Meral Gunaldi, Ridvan Ali
Korean J Intern Med. 2015;30(6):899-905. Published online October 30, 2015
Background/Aims: In this study, the sensitivity-specificity of galactomannan-enzyme immunoassay (GM-EIA) with a cut-off value of 0.5 for a single, two, or three consecutive positivity in the diagnosis of invasive pulmonary aspergillosis (IPA) in neutropenic patients with hematological malignancy was inves..
|
|
Sudden Atelectasis and Respiratory Failure in a Neutropenic Patient: Atypical Presentation of Pseudomembranous Necrotizing Bronchial Aspergillosis
Ji Yun Noh, Seok Jin Kim, Eun Hae Kang, Bo Kyoung Seo, Kyoung Ho Rho, Yang-Seok Chae, Byung Soo Kim
Korean J Intern Med. 2012;27(4):463-466. Published online November 27, 2012
Pseudomembranous necrotizing bronchial aspergillosis (PNBA) is a rare form of invasive aspergillosis with a very poor prognosis. The symptoms are non-specific, and the necrotizing plugs cause airway obstruction. Atelectasis and respiratory failure can be the initial manifestations. Recently, we t..
|
|
Case of Pseudomembranous Necrotizing Tracheobronchial Aspergillosis in an Immunocompetent Host
Hyo-Jeong Oh, Hak-Ryul Kim, Ki-Eun Hwang, So-Young Kim, Sun-Ho Ahn, Sei-Hoon Yang, Eun-Taik Jeong
Korean J Intern Med. 2006;21(4):279-282. Published online December 31, 2006
A 44-year-old Korean male died of rapidly progressive respiratory failure and refractory hypoxemia in 8 days after being admitted with a fever and dyspnea. The patient was diagnosed with pseudomembranous necrotizing tracheobronchial aspergillosis by fibroptic bronchoscopy and it was not related t..
|
|
|